2015Unpublished venueRequires access

Clinical research of chronic pelvic cavity pain syndrome treated with acupoint catgut embedding therapy

MA Yon

Open publisher page 0 citations

Abstract

Objective To explore the clinical efficacy of acupoint catgut embedding therapy on chronic pelvic cavity pain syndrome differentiated as kidney deficiency and stagnation of damp heat,and explore the impacts on plasma P substance(SP),plasma beta-endorphin(β-EP).Methods One hundred and eighty cases were randomly divided into a catgut embedding group(90 cases)and a western medication group(90 cases).In the western medication group,tamsulosin capsules 0.2 mg were prescribed for oral administration,once a day;indometacin sustained release tablets,25 mg,three times a day.Totally,the oral administration for 8 weeks was required.In the catgut embedding group,the acupoint catgut embedding therapy was applied to Qugu(CV 2),Shenshu(BL 23),Zhibian(BL 54),Huiyin(CV 1)and Sanyinjiao(SP 6),once every two weeks;the treatment of 4 weeks made one session,and two sessions were required.Before and after treatment,TCM symptom score,NIH-CPSI(the National Institute of Health Chronic Prostatitis Symptom Index)score,lecithin body numbers in prostatic fluid,score in SAS(self-rating anxiety scale),score in SDS(self-rating depression scale),the levels of SP andβ-EP,etc.were observed in the two groups,and the clinical efficacy was assessed in the two groups.Results(1)Ten cases were dropped in either group.The total effective rate was 91.25%(73/80)in the catgut embedding group,higher than 78.75%(63/80)in the western medication group(P0.05).(2)After treatment,TCM symptom score,total score in NIH-CPSI,pain score and the scores in SAS and SDS were all reduced as compared with those before treatment in the two groups(all P0.05).After treatment,TCM symptom score,total score and pain score in NIH-CPSI,and the scores in SAS and SDS in the catgut embedding group were both lower than those in the western medication group(all P0.05).(3)After treatment,the lecithin body numbers were both increased as compared with those before treatment in the two groups(both P0.05),and the result in the catgut embedding group was higher than that in the western medication group(P0.05).(4)After treatment,the SP level was lower than that before treatment in the two groups(both P0.05);the level ofβ-EP was increased as compared with that before treatment(both P0.05).The SP level in the catgut embedding group was lower than that in the western medication group(P0.05);the level ofβ-EP was higher than that in the western medication group(P0.05).Conclusion The acupoint catgut embedding therapy apparently relieves the clinical symptoms of chronic pelvic cavity pain syndrome differentiated as kidney deficiency and stagnation of damp heat as well as the condition of anxiety and depression,increases lecithin body numbers in prostatic fluid andβ-EP level and reduces SP level.

About this research paper

What this paper is about

Objective To explore the clinical efficacy of acupoint catgut embedding therapy on chronic pelvic cavity pain syndrome differentiated as kidney deficiency and stagnation of damp heat,and explore the impacts on plasma P substance(SP),plasma beta-endorphin(β-EP).Methods One hundred and eighty cases were randomly divided into a catgut embedding group(90 cases)and a western medication group(90 cases).In the western medication group,tamsulosin capsules 0.2 mg were prescribed for oral administration,once a day;indometacin sustained release tablets,25 mg,three times a day.Totally,the oral administration for 8 weeks was required.In the catgut embedding group,the acupoint catgut embedding therapy was applied to Qugu(CV 2),Shenshu(BL 23),Zhibian(BL 54),Huiyin(CV 1)and Sanyinjiao(SP 6),once every two weeks;the treatment of 4 weeks made one session,and two sessions were required.Before and after treatment,TCM symptom score,NIH-CPSI(the National Institute of Health Chronic Prostatitis Symptom Index)score,lecithin body numbers in prostatic fluid,score in SAS(self-rating anxiety scale),score in SDS(self-rating depression scale),the levels of SP andβ-EP,etc.were observed in the two groups,and the clinical efficacy was assessed in the two groups.Results(1)Ten cases were dropped in either group.The total effective rate was 91.25%(73/80)in the catgut embedding group,higher than 78.75%(63/80)in the western medication group(P0.05).(2)After treatment,TCM symptom score,total score in NIH-CPSI,pain score and the scores in SAS and SDS were all reduced as compared with those before treatment in the two groups(all P0.05).After treatment,TCM symptom score,total score and pain score in NIH-CPSI,and the scores in SAS and SDS in the catgut embedding group were both lower than those in the western medication group(all P0.05).(3)After treatment,the lecithin body numbers were both increased as compared with those before treatment in the two groups(both P0.05),and the result in the catgut embedding group was higher than that in the western medication group(P0.05).(4)After treatment,the SP level was lower than that before treatment in the two groups(both P0.05);the level ofβ-EP was increased as compared with that before treatment(both P0.05).The SP level in the catgut embedding group was lower than that in the western medication group(P0.05);the level ofβ-EP was higher than that in the western medication group(P0.05).Conclusion The acupoint catgut embedding therapy apparently relieves the clinical symptoms of chronic pelvic cavity pain syndrome differentiated as kidney deficiency and stagnation of damp heat as well as the condition of anxiety and depression,increases lecithin body numbers in prostatic fluid andβ-EP level and reduces SP level.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To explore the clinical efficacy of acupoint catgut embedding therapy on chronic pelvic cavity pain syndrome differentiated as kidney deficiency and stagnation of damp heat,and explore the impacts on plasma P substance(SP),plasma beta-endorphin(β-EP).Methods One hundred and eighty cases were randomly divided into a catgut embedding group(90 cases)and a western medication group(90 cases).In the western medication group,tamsulosin capsules 0.2 mg were prescribed for oral administration,once a day;indometacin sustained release tablets,25 mg,three times a day.Totally,the oral administration for 8 weeks was required.In the catgut embedding group,the acupoint catgut embedding therapy was applied to Qugu(CV 2),Shenshu(BL 23),Zhibian(BL 54),Huiyin(CV 1)and Sanyinjiao(SP 6),once every two weeks;the treatment of 4 weeks made one session,and two sessions were required.Before and after treatment,TCM symptom score,NIH-CPSI(the National Institute of Health Chronic Prostatitis Symptom Index)score,lecithin body numbers in prostatic fluid,score in SAS(self-rating anxiety scale),score in SDS(self-rating depression scale),the levels of SP andβ-EP,etc.were observed in the two groups,and the clinical efficacy was assessed in the two groups.Results(1)Ten cases were dropped in either group.The total effective rate was 91.25%(73/80)in the catgut embedding group,higher than 78.75%(63/80)in the western medication group(P0.05).(2)After treatment,TCM symptom score,total score in NIH-CPSI,pain score and the scores in SAS and SDS were all reduced as compared with those before treatment in the two groups(all P0.05).After treatment,TCM symptom score,total score and pain score in NIH-CPSI,and the scores in SAS and SDS in the catgut embedding group were both lower than those in the western medication group(all P0.05).(3)After treatment,the lecithin body numbers were both increased as compared with those before treatment in the two groups(both P0.05),and the result in the catgut embedding group was higher than that in the western medication group(P0.05).(4)After treatment,the SP level was lower than that before treatment in the two groups(both P0.05);the level ofβ-EP was increased as compared with that before treatment(both P0.05).The SP level in the catgut embedding group was lower than that in the western medication group(P0.05);the level ofβ-EP was higher than that in the western medication group(P0.05).Conclusion The acupoint catgut embedding therapy apparently relieves the clinical symptoms of chronic pelvic cavity pain syndrome differentiated as kidney deficiency and stagnation of damp heat as well as the condition of anxiety and depression,increases lecithin body numbers in prostatic fluid andβ-EP level and reduces SP level.

Key concepts: Medicine, Oral administration, Visual analogue scale, Internal medicine, Surgery, Anesthesia, Gastroenterology

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical research of chronic pelvic cavity pain syndrome treated with acupoint catgut embedding therapy — Research Paper | ScholarLens